InVivo Therapeutics Holdings Corp (NVIVQ)

[DDobserver]

I do not think NVIV is a buy out target anytime soon. The first trial has not been completed. Why would a company buy this out when there is nothing approved yet? You are putting the cart before the horse. If you research the past you will find that the CEO stated he would listen to offers but he had no intention of selling. Also in the corporate presentation it states "possible vertical integration with an established sales force." This could be worth 10 p/s in several years but not anytime soon.

Remember there is no revenue for the next 2 plus years minimum. Several other trials have to be started and completed over the next four years before this will be considered a winner. Then you have the other factors such as retiring chief medical officer, the election, the fed signaling that they are raising the rate which will effect the global markets, minimal information comes from the company leaving investors with nothing, and an executive staff and board of directors that are not purchasing the stock of the company that employs them. They do enjoy handsome salaries, benefits, stock options, and other perks.

You never did tell me based on your model what year NVIV would have a market cap of 600 million.